Beijing CorreGene Biotechnology Co., Ltd.
PrivateLast Round
VC Round
Nov 1, 2022
Total Funding Raised
$3.08M
Company Overview
Beijing CorreGene Biotechnology Co., Ltd. is a biotechnology company that develops innovative therapeutics based on T-cell receptors (TCRs) for the treatment of tumors, chronic infections, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing CorreGene Biotechnology Co., Ltd. Comparables
Compare Beijing CorreGene Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TCRCure Biopharma | 88% | |
| Lion TCR | 85% | |
| T-Knife | 81% |
Beijing CorreGene Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 1, 2022 | ||||
| VC Round | Nov 1, 2021 | ||||
| Angel | Dec 1, 2019 |
Beijing CorreGene Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anlong Fund | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 527% MoM, reaching 2K.
- Dec 1, 2019
$3.1M raised from Anlong Fund.
Beijing CorreGene Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing CorreGene Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Beijing CorreGene Biotechnology Co., Ltd. a public or private company?
Beijing CorreGene Biotechnology Co., Ltd. is a private company.
What is the current stock price of Beijing CorreGene Biotechnology Co., Ltd.?
Beijing CorreGene Biotechnology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Beijing CorreGene Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Beijing CorreGene Biotechnology Co., Ltd. is not publicly available.
Can I buy Beijing CorreGene Biotechnology Co., Ltd. stock?
Beijing CorreGene Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing CorreGene Biotechnology Co., Ltd.'s last funding round?
Beijing CorreGene Biotechnology Co., Ltd.'s most recent funding round was VC Round on November 1, 2022.
Who are the main investors in Beijing CorreGene Biotechnology Co., Ltd.?
Key investors in Beijing CorreGene Biotechnology Co., Ltd. include Anlong Fund.
Will Beijing CorreGene Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing CorreGene Biotechnology Co., Ltd..
How can I track Beijing CorreGene Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing CorreGene Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.